Works matching IS 03407004 AND DT 2022 AND VI 71 AND IP 3

Results: 21

Correction to: Chemotherapy: a double‑edged sword in cancer treatment.

Published in:

2022

By:

Behranvand, Nafiseh;
Nasri, Farzad;
Zolfaghari Emameh, Reza;
Khani, Pouria;
Hosseini, Asieh;
Garssen, Johan;
Falak, Reza

Publication type:

Correction Notice

Effect of HLA genotype on intravesical recurrence after bacillus Calmette–Guérin therapy for non-muscle-invasive bladder cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 727, doi. 10.1007/s00262-021-03032-0

By:

Kobayashi, Mizuki;
Fujiyama, Nobuhiro;
Tanegashima, Tokiyoshi;
Narita, Shintaro;
Yamamoto, Yoshiaki;
Fujimoto, Naohiro;
Ueda, Shohei;
Takeuchi, Ario;
Numakura, Kazuyuki;
Habuchi, Tomonori;
Matsuyama, Hideyasu;
Eto, Masatoshi;
Shiota, Masaki

Publication type:

Article

Anti-PD-(L)1 for KRAS-mutant advanced non-small–cell lung cancers: a meta-analysis of randomized–controlled trials.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 719, doi. 10.1007/s00262-021-03031-1

By:

Landre, Thierry;
Justeau, Gregoire;
Assié, Jean-Baptiste;
Chouahnia, Kader;
Davoine, Claire;
Taleb, Chérifa;
Chouaïd, Christos;
Duchemann, Boris

Publication type:

Article

Comparison of time to failure of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy: a consecutive analysis of patients having NSCLC with high PD-L1 expression.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 737, doi. 10.1007/s00262-021-03029-9

By:

Takumida, Hiroshi;
Horinouchi, Hidehito;
Masuda, Ken;
Shinno, Yuki;
Okuma, Yusuke;
Yoshida, Tatsuya;
Goto, Yasushi;
Yamamoto, Noboru;
Ohe, Yuichiro

Publication type:

Article

The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 705, doi. 10.1007/s00262-021-03026-y

By:

Kung, Pin-Jui;
Lai, Ting-Yu;
Cao, Jerry;
Hsu, Li-Chung;
Chiang, Tsai-Chen;
Ou-Yang, Pu;
Tsai, Ching-Yi;
Tsai, Yi-Fen;
Lin, Chih-Wen;
Chen, Chien-Chia;
Tsai, Meng-Kun;
Tien, Yu-Wen;
Lee, Chih-Yuan

Publication type:

Article

ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 645, doi. 10.1007/s00262-021-03022-2

By:

Xu, Houshi;
Zhang, Anke;
Han, Xiaying;
Li, Yanning;
Zhang, Zeyu;
Song, Liying;
Wang, Wei;
Lou, Meiqing

Publication type:

Article

Circulating PD-L1 is associated with T cell infiltration and predicts prognosis in patients with CRLM following hepatic resection.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 661, doi. 10.1007/s00262-021-03021-3

By:

Chen, Xiuxing;
Du, Ziming;
Huang, Mayan;
Wang, Deshen;
Fong, William Pat;
Liang, Jieying;
Fan, Lei;
Wang, Yun;
Yang, Hui;
Chen, Zhigang;
Hu, Mingtao;
Xu, Ruihua;
Li, Yuhong

Publication type:

Article

An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 747, doi. 10.1007/s00262-021-03020-4

By:

Wu, Pu;
Sun, Wei;
Zhang, Hao

Publication type:

Article

Identification of LIPH as an unfavorable biomarkers correlated with immune suppression or evasion in pancreatic cancer based on RNA-seq.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 601, doi. 10.1007/s00262-021-03019-x

By:

Zhuang, Hongkai;
Chen, Xinming;
Wang, Ying;
Huang, Shanzhou;
Chen, Bo;
Zhang, Chuanzhao;
Hou, Baohua

Publication type:

Article

Circulating regulatory T cells predict efficacy and atypical responses in lung cancer patients treated with PD-1/PD-L1 inhibitors.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 579, doi. 10.1007/s00262-021-03018-y

By:

Kang, Da Hyun;
Chung, Chaeuk;
Sun, Pureum;
Lee, Da Hye;
Lee, Song-I;
Park, Dongil;
Koh, Jeong Suk;
Kim, Yoonjoo;
Yi, Hyon-Seung;
Lee, Jeong Eun

Publication type:

Article

Efficacy and safety of PD-L1 inhibitors versus PD-1 inhibitors in first-line treatment with chemotherapy for extensive-stage small-cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 637, doi. 10.1007/s00262-021-03017-z

By:

Yu, Hui;
Chen, Ping;
Cai, Xiuyu;
Chen, Chen;
Zhang, Xuanye;
He, Lina;
Zhou, Yixin;
Hong, Shaodong;
Zhang, Bei

Publication type:

Article

A comprehensive model based on temporal dynamics of peripheral T cell repertoire for predicting post-treatment distant metastasis of nasopharyngeal carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 675, doi. 10.1007/s00262-021-03016-0

By:

Zhang, Yajing;
Zhu, Yujie;
Wang, Jiaqi;
Xu, Yi;
Wang, Zekun;
Liu, Yang;
Di, Xuebing;
Feng, Lin;
Zhang, Ye

Publication type:

Article

Transcriptomic signatures of tumors undergoing T cell attack.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 553, doi. 10.1007/s00262-021-03015-1

By:

Gokuldass, Aishwarya;
Schina, Aimilia;
Lauss, Martin;
Harbst, Katja;
Chamberlain, Christopher Aled;
Draghi, Arianna;
Westergaard, Marie Christine Wulff;
Nielsen, Morten;
Papp, Krisztian;
Sztupinszki, Zsofia;
Csabai, Istvan;
Svane, Inge Marie;
Szallasi, Zoltan;
Jönsson, Göran;
Donia, Marco

Publication type:

Article

Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia and its implication for the activity of CAP-100, a novel therapeutic anti-CCR7 antibody.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 627, doi. 10.1007/s00262-021-03014-2

By:

Mateu-Albero, Tamara;
Juárez-Sánchez, Raquel;
Loscertales, Javier;
Mol, Wim;
Terrón, Fernando;
Muñoz-Calleja, Cecilia;
Cuesta-Mateos, Carlos

Publication type:

Article

Chemotherapy: a double-edged sword in cancer treatment.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 507, doi. 10.1007/s00262-021-03013-3

By:

Behranvand, Nafiseh;
Nasri, Farzad;
Zolfaghari Emameh, Reza;
Khani, Pouria;
Hosseini, Asieh;
Garssen, Johan;
Falak, Reza

Publication type:

Article

Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 565, doi. 10.1007/s00262-021-03011-5

By:

Mizuno, Tomoya;
Kamai, Takao;
Tsuzuki, Toyonori;
Nishihara, Daisaku;
Kijima, Toshiki;
Arai, Kyoko;
Yoshida, Ken-Ichiro

Publication type:

Article

Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemia.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 689, doi. 10.1007/s00262-021-03009-z

By:

Zhang, Xian;
Yang, Junfang;
Li, Jingjing;
Li, Wenqian;
Song, Dan;
Lu, Xin-an;
Wu, Fei;
Li, Jianqiang;
Chen, Dandan;
Li, Xiangqun;
Xu, Zhongwei;
Liu, Shuqiang;
Li, Ziyu;
Ying, Kui;
Lu, Peihua

Publication type:

Article

A secondary role for hypoxia and HIF1 in the regulation of (IFNγ-induced) PD-L1 expression in melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 529, doi. 10.1007/s00262-021-03007-1

By:

van Duijn, Anneloes;
Willemsen, Karin J.;
van Uden, Nathalie O. P.;
Hoyng, Lieke;
Erades, Sterre;
Koster, Jan;
Luiten, Rosalie M.;
Bakker, Walbert J.

Publication type:

Article

Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 541, doi. 10.1007/s00262-021-03002-6

By:

Hoffmann, Elgin;
Paulsen, Frank;
Schaedle, Philipp;
Zips, Daniel;
Gani, Cihan;
Rammensee, Hans-Georg;
Gouttefangeas, Cécile;
Eckert, Franziska

Publication type:

Article

Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 613, doi. 10.1007/s00262-021-02982-9

By:

Thangaraj, Jaya Lakshmi;
Phan, Minh-Trang Thi;
Kweon, SoonHo;
Kim, Jinho;
Lee, Jong-Min;
Hwang, Ilwoong;
Park, Jeehun;
Doh, Junsang;
Lee, Seung-Hwan;
Vo, Manh-Cuong;
Chu, Tan-Huy;
Song, Ga-Young;
Ahn, Seo-Yeon;
Jung, Sung-Hoon;
Kim, Hyeoung-Joon;
Cho, Duck;
Lee, Je-Jung

Publication type:

Article

Pilot study to determine the safety and feasibility of deceased donor liver natural killer cell infusion to liver transplant recipients with hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 589, doi. 10.1007/s00262-021-03005-3

By:

Ohira, Masahiro;
Hotta, Ryuichi;
Tanaka, Yuka;
Matsuura, Toshiharu;
Tekin, Akin;
Selvaggi, Gennaro;
Vianna, Rodrigo;
Ricordi, Camillo;
Ruiz, Phillip;
Nishida, Seigo;
Tzakis, Andreas G.;
Ohdan, Hideki

Publication type:

Article